期刊文献+

应重视化疗在肌层浸润性膀胱癌保留膀胱治疗中的作用 被引量:9

Applications of chemotherapy in muscle invasive bladder cancer with bladder preservation
下载PDF
导出
摘要 化疗是近年来肌层浸润性膀胱癌重要的辅助治疗手段,对于临床要求保留膀胱的患者意义重大。本文介绍了新辅助化疗和辅助化疗的作用及效果,对经尿道根治性膀胱肿瘤切除术(transurethral resection of bladder tumor,TURBT)联合化疗以及膀胱部分切除术联合化疗的方法及疗效进行综述,同时对一些特殊患者例如肾脏移植患者及透析患者的化疗进行了介绍;最后对当前化疗中存在的药物敏感性问题加以阐述,并对今后化疗在肌层浸润性膀胱癌保留膀胱的发展前景进行了展望。 Chemotherapy has been developing to be an important adjuvant treatment methods in treatment of muscle invasive bladder cancer in recent years. Such method is meaningful for patients who want to preserve the bladder. The author summarized the role and effect of neoadjuvant chemotherapy and adjuvant chemotherapy. This article reviews the methods and effect of radical transurethral resection of bladder tumor with chemotherapy and partial cystectomy with chemotherapy. Data of several special patients including patients with renal transplantation and dialysis patients undergoing chemotherapy are presented. The problems existing in current drug sensitivity of chemotherapy are discussed finally. The future of chemotherapy in muscle invasive bladder cancer with bladder preservation is predicted.
作者 田野
出处 《首都医科大学学报》 CAS 2014年第3期269-272,共4页 Journal of Capital Medical University
关键词 化疗 膀胱癌 经尿道膀胱肿瘤切除 膀胱部分切除 chemotherapy muscle invasive bladder cancer transurethral resection of bladder tumor partial cystectomy
  • 相关文献

参考文献24

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos, 2012[J]. CA Cancer J Clin, 2012,62 (5) :283-298.
  • 2Martini T, Mayr R, Wehrberger C, et al. Comparison of radical cystectomy with conservative treatment in geriatric ( 1> 80) patients with muscle-invasive bladder cancer [ J ]. Int Braz ] Urol, 2013,39(5) :622-630.
  • 3Kitagawa Y, Izumi K, Miwa S, et al. Retrospective analy- sis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-in- vasive bladder cancer [ J 1. Anticancer Res, 2013,33 (10) : 4497- 4503.
  • 4樊晓栋,姜庆,王家武.新辅助化疗对肌层浸润性膀胱癌预后影响的Meta分析[J].第三军医大学学报,2011,33(2):196-199. 被引量:19
  • 5Teramukai S, Nishiyama H, Matsui Y, et al. Evaluation for surrogacy of end points by using data from observational studies: tumor downstaging for evaluating neoadjuvant chemotherapy in invasive bladder cancer [ J 1. Clin Cancer Res, 2006,12(1) :139-143.
  • 6Bellmunt J, von der Maase H, Mead G M, et al. Random- ized phase m study comparing paclitaxel/cisplatin/gemcit- abine and gemcitabine/cisplatin in patients with locally ad- vanced or metastatic urothelial cancer without prior systemic therapy : EORTC intergroup study 30987 [ J ]. J Clin Oncol, 2012,30(10) : 1107- 1113.
  • 7Volkmer B G, Kuefer R, Bartsch G Jr, et al. Effect of a pT0 cysteetomy specimen without neoadjuvant therapy on survival[ J ]. Cancer, 2005,104 ( 11 ) :2384- 2391.
  • 8李双辉,张志宏,徐勇,牛越,冯国伟,孔繁辉,党瑞锋.根治性经尿道膀胱肿瘤电切术加化疗治疗肌层浸润性膀胱癌的疗效分析[J].中华泌尿外科杂志,2012,33(3):215-218. 被引量:65
  • 9Balar A, Bajorin D F, Milowsky M I. Management of inva- sive bladder cancer in patients who are not candidates for or decline cystectomy[ J ]. Ther Adv Urol, 2011,3 (3):107- 117.
  • 10Mayadagli A, Kocak M, Demir O, et al. Elective bladder preservation with muhimodality treatment for bladder cancer [J]. J BUON, 2012,17(3) :483-489.

二级参考文献76

  • 1侯建国,杨波,孙颖浩,万蓬.浸润性膀胱癌患者的保留膀胱综合治疗[J].临床泌尿外科杂志,2004,19(10):619-620. 被引量:12
  • 2王莉,刘风花,刘若男.新辅助化疗对宫颈鳞癌细胞增殖与凋亡的影响[J].第三军医大学学报,2005,27(15):1599-1600. 被引量:1
  • 3周芳坚,刘卓炜,余绍龙,韩辉,秦自科,李永红,王欢.改良全膀胱切除原位新膀胱术96例报告[J].中华泌尿外科杂志,2006,27(8):549-551. 被引量:39
  • 4罗宏,周宏,李元,王传麟,刘南,朱葆捷,毛林.经尿道膀胱肿瘤电切术(TURBT)治疗浸润性膀胱癌[J].现代肿瘤医学,2006,14(11):1423-1424. 被引量:14
  • 5Parkin M D, Bray F, Ferlay J, et al. Global Cancer Statistics,2002 [J]. CA CancerJClin, 2005, 55(2): 74-108.
  • 6Stein J P, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invaslve bladder cancer: long-term results in 1054 patients [J]. JClin Oncol, 2001, 19(3): 666 -675.
  • 7Stein J P, Quek M L, Skinner D G. Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale [J]. BJUInt, 2006, 97(2): 227-231.
  • 8Nieuwenhuijzen J A, Bex A, Meinhardt W, et al. Neocadjuvant roethotrex- ate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer[J]. J Urol, 2005, 174(1) : 80-85.
  • 9Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration [ J]. Eur Urol, 2005, 48 ( 2 ) : 202 - 205.
  • 10Diestra J E, Condom E, Del-Muro X G, et al. Expression of multidrug resistance proteins P-glycoprotein, muhidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications[J]. J Urol, 2003, 170(4 Pt 1) : 1383 - 1387.

共引文献124

同被引文献62

引证文献9

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部